In my prior posts on “99 Per Cent Survival” and “Health Update – Wonder Drug for CCP Virus” I discussed the wonder drug ivermectin and one doctor who was achieving a 99% survival from those among the hardest hit with the virus. His treatment protocol for moderate to high risk patients includes 0.4-0.5mg/kg/day for 5-7 days for ivermectin as one of the key ingredients and is the wonder drug that helps save lives during this pandemic. Now that major health agencies are shedding doubt on this wonder drug, he also researched other drugs that experience the same characteristic as a carrier for zinc. No doubt the disinformation campaign will begin on those shortly by those who wish everyone to take the lethal vaccine (see below for how lethal it really is). But, the primary focus in this article is to highlight the science based, evidence based, and data based analysis of ivermectin.
Ivermectin has so few side effects that 3rd world nations are deeming it the wonder drug.
In this post I will show you the science based, evidence based, and data based approach that allows people to make those claims. After all, claims like that should not be made on theories and speculation. We are well into this pandemic and there should be evidence that backs up claims that it helps quite a few people and harms nearly no one.
Some people might ask why bother when there are proven vaccines that, by all claims in the main stream, are doing nothing but saving lives. Again, that type of a claim needs to be backed up by science based, evidence based, data based review. Under such review of the data, those claims are without merit. Why? In the Vaccine Adverse Event Reporting System (VAERS) there are over 490,000 adverse events reported about the COVID-19 series of vaccines in 2021 alone. Of those there are 6,000 deaths in the US in 2021 for people who received the vaccine and an adverse event was reported (either by the family members or the doctors at the hospital). There were also over 3,000 pregnancies with complications that resulted in a still birth or miscarriage. All of this data is available at wonder.cdc.gov. From the evidence and the data the claim that this is the worse vaccine in all of history is scientifically based in fact. Previous vaccines were pulled from administration if it resulted in 50 deaths. This series of vaccines do not follow the normal precautions. Why not when a well known treatment protocol cures over 99% of all high risk patients?
Let’s examine those claims about ivermectin even closer. Just like the evidence based approach for adverse events, what studies exist to show the efficacy of ivermectin?
On the National Library of Medicine site, there are over 8000 published papers with insight into the efficacy of ivermectin. A recent publication in the Indian Dermatology Online Journal concludes that “The drug has already found its way in many regional, state, and International protocols of clinical care though more evidence would be welcome to establish its role and as evidenced by the data in Table 3, a growing evidence of its use is being published and we feel it is one of the few drugs that has transcended in-vitro data to clinical applicability.” And “The drug has been used safely in MDA programs for more than 25 years. Although high doses have been shown in certain animals to cause CNS toxicity manifested by emesis, mydriasis, and ataxia, its poor penetration of the blood–brain barrier prevents any toxic effect.”
This study also noted “Shields SARS-CoV-2 spike protein preventing its binding to the CD147 transmembrane receptor and ACE2” and thus prevents the spike protein from adhering to the cellular membranes. And although it cautioned about use during pregnancy because of lack of results, it specifically noted this, “The use of IVM in mass treatment campaigns for more than 2 decades has occasionally resulted in the inadvertent administration of IVM to pregnant women with no adverse effects recorded.” And after birth, this statement “The drug is excreted into breast milk and may attain concentrations of around 30% of that in plasma. But <10% of what goes into breast milk has been estimated to be taken up by the infant, which has been regarded as clinically insignificant.”
For children and infants the study showed “IVM is conventionally not recommended for children under 15 kg and less than 5 years of age (see above) but clinical safety in infants and children has been demonstrated in a recent large multicentric observational study. Levy et al. reported data on 170 infants and children aged 1–64 months, with a bodyweight of 4–14·5 kg, who were treated with 1-2 doses of IVM for scabies. Only seven reported mild adverse events and there were no serious side effects.” That is compared to the over 400 children who have died as a result of the vaccine.
The final conclusion from this study was
IVM is a drug that is safe, cheap, and widely available with multimodal action. The wide applicability with mass prophylaxis campaigns in various tropical disorders certifies its safety. The dermatological indications extend beyond scabies and pediculosis. The repurposing of this drug for COVID-19 is based on firm in-vitro data and therapeutic data suggests that it is a useful drug in the early virus replicative phase of the disease. It can be given at higher doses based on the available data which may achieve the ideal serum levels for an antiviral action. While it has established a firm place in the management of several nematodal and ectoparasitic infections, the anti-inflammatory, anti-cancer, and anti-viral/bacterial role of IVM make it a versatile drug, the full potential of it will evolve over the years.INDIAN DERMATOL ONLINE J. 2021 JUL-AUG; 12(4): 500–514
Although this next article is not a scientific study, acknowledgement is given as the source of the above information.
In this article, Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19, the conclusion reached is the same:
Meta-analyses based on 18 randomized controlled treatment trials of ivermectin in COVID-19 have found large, statistically significant reductions in mortality, time to clinical recovery, and time to viral clearance. Furthermore, results from numerous controlled prophylaxis trials report significantly reduced risks of contracting COVID-19 with the regular use of ivermectin. Finally, the many examples of ivermectin distribution campaigns leading to rapid population-wide decreases in morbidity and mortality indicate that an oral agent effective in all phases of COVID-19 has been identified.Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
Given that the vaccine has now permanently injured more children than it ever has helped, and that the vaccine has resulted in the termination of countless pregnancies, will the medical community perform a due diligence and roll out a campaign over the whole world so that the vaccination of an experimental vaccines can be stopped. The long term health catastrophe is not fully known, but the VAERS system was noted in an MIT study that it only included 1-10% of all cases of adverse events. If we error on the conservative side and believe 10% of adverse events are reported, a quick calculation means the 6,000 deaths in the US might possibly be 60,000+ deaths. Ivermectin has been used for 25 years and has a proven track record of pros and cons. The cons are minimal, while the positive benefits lead it to being known as the wonder drug across many nations.
There are few drugs that can seriously lay claim to the title of ‘Wonder drug’, penicillin and aspirin being two that have perhaps had greatest beneficial impact on the health and wellbeing of Mankind. But ivermectin can also be considered alongside those worthy contenders, based on its versatility, safety and the beneficial impact that it has had, and continues to have, worldwide—especially on hundreds of millions of the world’s poorest people.Ivermectin, ‘Wonder drug’ from Japan: the human use perspective